植物抗体市场－全球产业规模、份额、趋势、机会和预测，按基因改造作物、技术、应用、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球植物抗体市场规模为6,091万美元，预计2030年将以8.18%的复合年增长率成长至9,763万美元。植物抗体是在基因改造植物中生产的重组抗体，旨在用于多种治疗和诊断应用。该市场的成长主要得益于植物表达系统的固有优势，特别是与传统的哺乳动物细胞培养相比，其生产成本更低、可扩展性更强，并且降低了人畜病原体污染的风险。此外，由于宿主植物生长迅速，这些系统还能加快生产速度。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球植物抗体市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 基因改造作物（烟草、豆类、谷物、种子和块茎、水果和蔬菜、其他）
  • 按技术（传统方法、组织培养、育种和有性杂交、基因改造种子、其他）
  • 依应用领域（自体免疫疾病、癌症、传染病、免疫接种、牙科、其他）
  • 按最终用户（生物技术和製药公司、学术和研究机构、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美植物抗体市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲植物抗体市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区植物抗体市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲植物抗体市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲植物抗体市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球植物抗体市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• PlantForm Corporation
• Planet Biotechnology Inc.
• iBio, Inc.
• Mapp Biopharmaceutical, Inc. (Allergan, Inc.)
• Medicago Inc.
• NOMAD Bioscience GmbH
• Ventria Bioscience Inc.
• Agrisera AB
• Creative Biolabs, Inc.
• Protalix BioTherapeutics Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Plantibodies Market , valued at USD 60.91 Million in 2024, is projected to experience a CAGR of 8.18% to reach USD 97.63 Million by 2030. Plantibodies are recombinant antibodies produced in genetically modified plants, designed for diverse therapeutic and diagnostic applications. The market's growth is predominantly supported by the intrinsic advantages of plant-based expression systems, notably lower production costs, superior scalability compared to conventional mammalian cell cultures, and a mitigated risk of contamination from human or animal pathogens. These systems also offer accelerated production timelines due to the rapid growth characteristics of host plants.

Key Market Drivers

The Global Plantibodies Market is primarily driven by cost-effective production and scalability, along with a significantly reduced risk of pathogen contamination. Plant-based expression systems inherently bypass the high capital investments and operational costs associated with traditional mammalian cell cultures, which demand complex sterile bioreactor environments. This allows for scalable cultivation in diverse settings, enabling high-volume biopharmaceutical production at lower per-unit expenses. According to the National Science Foundation's Partnerships for Innovation Research Partnerships (PFI-RP) project, in its 2024 abstract, plant-based biomanufacturing platforms target production exceeding 500 mg per kilogram of plant fresh weight for functional human blood proteins, demonstrating substantial scalability.

Key Market Challenges

The intricate and developing regulatory landscape for plant-derived pharmaceuticals poses a substantial impediment to the growth of the Global Plantibodies Market. The evolving nature of guidelines for genetically modified organisms used in therapeutic production creates uncertainty for developers and investors alike. This complexity often translates into extended timelines for product development and approval, delaying market entry for innovative plantibody candidates.

The compliance burden imposed by diverse and sometimes overlapping regulations significantly increases operational costs for companies engaged in plantibody manufacturing. According to the National Association of Manufacturers, the average manufacturer in the United States incurred over $29,000 per employee per year in federal regulatory compliance costs in 2022, measured in 2023 dollars. This substantial financial overhead, applicable across the manufacturing sector, directly impacts the economic viability of novel plant-based biopharmaceutical ventures.

Key Market Trends

The integration of artificial intelligence into plantibody discovery and optimization is accelerating development timelines and enhancing therapeutic precision. AI algorithms efficiently analyze extensive protein data, predicting optimal modifications for improved binding affinity and efficacy, thereby streamlining initial drug development phases. According to PhRMA, the biopharmaceutical industry invested nearly $101 billion in research and development in 2022, highlighting the sector's robust commitment to innovation enabling advanced computational methods. For example, Stanford scientists developed a machine learning method achieving a 25-fold improvement in a SARS-CoV-2 antibody by predicting molecular changes, as reported in Science in July 2024. This showcases AI's direct influence on identifying highly effective plantibody variants.

Key Market Players

• PlantForm Corporation
• Planet Biotechnology Inc.
• iBio, Inc.
• Mapp Biopharmaceutical, Inc. (Allergan, Inc.)
• Medicago Inc.
• NOMAD Bioscience GmbH
• Ventria Bioscience Inc.
• Agrisera AB
• Creative Biolabs, Inc.
• Protalix BioTherapeutics Inc.

Report Scope:

In this report, the Global Plantibodies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Plantibodies Market , By Transgenic Crop:

• Tobacco
• Legumes
• Cereals
• Seeds & Tubers
• Fruits & Vegetables
• Others

Plantibodies Market , By Technique:

• Conventional Method
• Tissue Culture
• Breeding & Sexual Crossing
• Transgenic Seeds
• Others

Plantibodies Market , By Application:

• Autoimmune Diseases
• Cancer
• Infectious Diseases
• Immunization
• Dentistry
• Others

Plantibodies Market , By End User:

• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutes
• Others

Plantibodies Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Plantibodies Market .

Available Customizations:

Global Plantibodies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Plantibodies Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Transgenic Crop (Tobacco, Legumes, Cereals, Seeds & Tubers, Fruits & Vegetables, Others)
  • 5.2.2. By Technique (Conventional Method, Tissue Culture, Breeding & Sexual Crossing, Transgenic Seeds, Others)
  • 5.2.3. By Application (Autoimmune Diseases, Cancer, Infectious Diseases, Immunization, Dentistry, Others)
  • 5.2.4. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Plantibodies Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Transgenic Crop
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Plantibodies Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Transgenic Crop
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Plantibodies Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Transgenic Crop
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Plantibodies Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Transgenic Crop
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Plantibodies Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Transgenic Crop
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Plantibodies Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Transgenic Crop
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Plantibodies Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Transgenic Crop
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Plantibodies Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Transgenic Crop
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Plantibodies Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Transgenic Crop
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Plantibodies Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Transgenic Crop
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Plantibodies Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Transgenic Crop
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Plantibodies Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Transgenic Crop
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Plantibodies Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Transgenic Crop
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Plantibodies Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Transgenic Crop
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Plantibodies Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Transgenic Crop
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Plantibodies Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Transgenic Crop
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Plantibodies Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Transgenic Crop
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Plantibodies Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Transgenic Crop
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Plantibodies Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Transgenic Crop
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Plantibodies Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Transgenic Crop
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Plantibodies Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Transgenic Crop
  • 10.2.2. By Technique
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Plantibodies Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Transgenic Crop
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Plantibodies Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Transgenic Crop
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Plantibodies Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Transgenic Crop
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Plantibodies Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. PlantForm Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Planet Biotechnology Inc.
• 15.3. iBio, Inc.
• 15.4. Mapp Biopharmaceutical, Inc. (Allergan, Inc.)
• 15.5. Medicago Inc.
• 15.6. NOMAD Bioscience GmbH
• 15.7. Ventria Bioscience Inc.
• 15.8. Agrisera AB
• 15.9. Creative Biolabs, Inc.
• 15.10. Protalix BioTherapeutics Inc.

16. Strategic Recommendations

17. About Us & Disclaimer